1.5 ML somapacitan-beco 10 MG/ML Pen Injector [Sogroya]
somapacitan-beco
RxCUI: 2636954
What the CMS Formulary Data Shows for 1.5 ML somapacitan-beco 10 MG/ML Pen Injector [Sogroya]
Per the CMS 2026 Part D formulary file, 1.5 ML somapacitan-beco 10 MG/ML Pen Injector [Sogroya] (RxNorm concept RXCUI 2636954, generic name somapacitan-beco) appears on 6 distinct formulary files spanning 15 Medicare Part D plan offerings - 0.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 3.2.
Real-world access to 1.5 ML somapacitan-beco 10 MG/ML Pen Injector [Sogroya] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 28 Part D beneficiaries filled 1.5 ML somapacitan-beco 10 MG/ML Pen Injector [Sogroya] in 2023, with total plan-and-beneficiary spending of $163,197 and an average per-beneficiary annual cost of $5,828.48. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 1.5 ML somapacitan-beco 10 MG/ML Pen Injector [Sogroya] today.
Coverage Details
- Formularies covering
- 6
- Plans covering
- 15
- Coverage rate
- 0.3%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 100% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 28
- Total spending
- $163,197
- Avg per beneficiary
- $5,828.48
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 1.5 ML somapacitan-beco 10 MG/ML Pen Injector [Sogroya]
15 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Mass General Brigham SCO (HMO D-SNP) | MASS GENERAL BRIGHAM HEALTH PLAN, INC | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | MASS GENERAL BRIGHAM HEALTH PLAN, INC | T1 | Yes | $0 | MA |
| CalOptima Health OneCare Complete (HMO D-SNP) | ORANGE COUNTY HEALTH AUTHORITY | T2 | Yes | $0 | CA |
| Geisinger Gold Preferred Complete Rx (PPO) | GEISINGER INDEMNITY INSURANCE COMPANY | T5 | Yes | $0 | PA |
| Geisinger Gold Secure Rx (HMO D-SNP) | GEISINGER HEALTH PLAN | T5 | Yes | $0 | PA |
| Geisinger Gold Classic 360 Rx (HMO) | GEISINGER HEALTH PLAN | T5 | Yes | $0 | PA |
| Geisinger Gold Classic Essential Rx (HMO) | GEISINGER HEALTH PLAN | T5 | Yes | $0 | PA |
| Mass General Brigham Advantage (PPO) | Mass General Brigham Health Plan, Inc. | T5 | Yes | $0 | MA |
| Geisinger Gold Value Rx (HMO) | GEISINGER HEALTH PLAN | T5 | Yes | $23.00 | PA |
| Geisinger Gold Classic Complete Rx (HMO) | GEISINGER HEALTH PLAN | T5 | Yes | $48.00 | PA |
| Mass General Brigham Advantage Secure (HMO-POS) | Mass General Brigham Health Plan, Inc. | T5 | Yes | $62.00 | MA |
| Mass General Brigham Advantage Premier (PPO) | Mass General Brigham Health Plan, Inc. | T5 | Yes | $79.70 | MA |
| Geisinger Gold Classic Advantage Rx (HMO) | GEISINGER HEALTH PLAN | T5 | Yes | $99.30 | PA |
| Geisinger Gold Preferred Advantage Rx (PPO) | GEISINGER INDEMNITY INSURANCE COMPANY | T5 | Yes | $112.00 | PA |
| Mass General Brigham Advantage Signature (PPO) | Mass General Brigham Health Plan, Inc. | T5 | Yes | $147.20 | MA |
Frequently Asked Questions
Is 1.5 ML somapacitan-beco 10 MG/ML Pen Injector [Sogroya] covered by Medicare Part D?
Yes, 1.5 ML somapacitan-beco 10 MG/ML Pen Injector [Sogroya] is covered by 15 Medicare Part D plans (0.3% of all Part D formularies).
What tier is 1.5 ML somapacitan-beco 10 MG/ML Pen Injector [Sogroya] on Medicare Part D plans?
1.5 ML somapacitan-beco 10 MG/ML Pen Injector [Sogroya] averages Tier 3.2 across Part D plans, ranging from Tier 1 to Tier 5.
Does 1.5 ML somapacitan-beco 10 MG/ML Pen Injector [Sogroya] require prior authorization?
100% of Part D formularies require prior authorization for 1.5 ML somapacitan-beco 10 MG/ML Pen Injector [Sogroya]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on 1.5 ML somapacitan-beco 10 MG/ML Pen Injector [Sogroya]?
In 2023, total Medicare Part D spending on 1.5 ML somapacitan-beco 10 MG/ML Pen Injector [Sogroya] was $163,197, covering 28 beneficiaries. The average spend per beneficiary was $5,828.48.
Read our methodology - how this data is sourced, computed, and verified.